These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
143 related items for PubMed ID: 1287614
1. A multicentre trial of cefaclor advanced formulation versus cefaclor in the treatment of acute bronchitis. Alanis A, Longest KA, Senetar JE, Dere WH. Postgrad Med J; 1992; 68 Suppl 3():S24-8, discussion S29. PubMed ID: 1287614 [Abstract] [Full Text] [Related]
2. Cefaclor AF versus cefaclor in acute exacerbations of chronic bronchitis. Grossman RF. Postgrad Med J; 1992; 68 Suppl 3():S30-6; discussion S36-7. PubMed ID: 1287616 [Abstract] [Full Text] [Related]
3. Cefaclor AF in the treatment of streptococcal pharyngitis/tonsillitis. Derriennic M, Voi M, Thoren LM, Black SA, Dere WH. Postgrad Med J; 1992; 68 Suppl 3():S43-6; discussion S46-8. PubMed ID: 1287618 [Abstract] [Full Text] [Related]
4. Comparative trials of cefaclor AF in uncomplicated cystitis and asymptomatic bacteriuria. Hamilton-Miller JM, Iravani A, Brumfitt W, Byers KS, Dere WH. Postgrad Med J; 1992; 68 Suppl 3():S60-6; discussion S66-7. PubMed ID: 1287620 [Abstract] [Full Text] [Related]
5. Cefaclor af versus amoxycillin/clavulanate in acute bacterial exacerbations of chronic bronchitis: a randomised multicentre study. Bandak SI, Bolzon LD, Turnak MR, Johns D, Henle SK, Allen BS. Int J Clin Pract; 1999 Dec; 53(8):578-83. PubMed ID: 10692750 [Abstract] [Full Text] [Related]
6. Cefaclor AF: correlation of microbiology and clinical outcome. Thornsberry C. Postgrad Med J; 1992 Dec; 68 Suppl 3():S10-6. PubMed ID: 1287612 [Abstract] [Full Text] [Related]
8. Interrelationship between the pharmacokinetics and pharmacodynamics of cefaclor advanced formulation in patients with acute exacerbation of chronic bronchitis. Cazzola M, Di Perna F, Boveri B, Di Marco F, Diamare F, Centanni S. J Chemother; 2000 Jun; 12(3):216-22. PubMed ID: 10877516 [Abstract] [Full Text] [Related]
9. Effectiveness of short-course therapy (5 days) with grepafloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis. DeAbate CA, Bettis R, Munk ZM, Fleming H, Munn NJ, Riffer E, Bagby B, Giguere G, Collins JJ. Clin Ther; 1999 Jan; 21(1):172-88. PubMed ID: 10090434 [Abstract] [Full Text] [Related]
10. Comparative efficacy and safety evaluation of cefaclor vs amoxycillin + clavulanate in children with Acute Otitis Media (AOM). Aggarwal M, Sinha R, Murali MV, Trihan P, Singhal PK. Indian J Pediatr; 2005 Mar; 72(3):233-8. PubMed ID: 15812119 [Abstract] [Full Text] [Related]
11. Efficacy of cefaclor AF in the treatment of skin and skin-structure infections. Schupbach CW, Olovich KG, Dere WH. Clin Ther; 1992 Mar; 14(3):470-9. PubMed ID: 1638588 [Abstract] [Full Text] [Related]
12. Comprehensive safety profile of cefaclor AF in respiratory, urinary tract and skin infections. Stotka JL, Senetar JE, Therasse DG, Dere WH. Postgrad Med J; 1992 Mar; 68 Suppl 3():S73-7; discussion S78-80. PubMed ID: 1287622 [Abstract] [Full Text] [Related]
14. A comparison of a five-day regimen of cefdinir with a seven-day regimen of loracarbef for the treatment of acute exacerbations of chronic bronchitis. Paster RZ, McAdoo MA, Keyserling CH, Nemeth MA, Tack KJ, Griffin TJ. Int J Clin Pract; 2000 Jun; 54(5):293-9. PubMed ID: 10954955 [Abstract] [Full Text] [Related]
16. Loracarbef (LY163892) versus amoxicillin/clavulanate in the treatment of acute bacterial exacerbations of chronic bronchitis. Zeckel ML, Jacobson KD, Guerra FJ, Therasse DG, Farlow D. Clin Ther; 1992 Jun; 14(2):214-29. PubMed ID: 1611645 [Abstract] [Full Text] [Related]
17. A comparison of cefaclor and tetracycline in the treatment of bacterial bronchitis. Hurst DJ. Clin Ther; 1984 Jun; 6(2):163-9. PubMed ID: 6231104 [Abstract] [Full Text] [Related]